{"organizations": [], "uuid": "ac36e913f58f7e85f07fb9b995fabcf1df857d62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?d=20180525&i=OV8HDAOP7&w=1200&r=OV8HDAOP7&t=2", "site_section": "http://feeds.reuters.com/reuters/UKVideoLatest", "section_title": "Reuters Video: Latest Videos UK", "url": "https://uk.reuters.com/video/2018/05/25/bayer-cuts-monsanto-synergy-target-by-30?videoId=430252473", "country": "US", "domain_rank": 408, "title": "Bayer cuts Monsanto synergy target by $300 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-25T19:49:00.000+03:00", "replies_count": 0, "uuid": "ac36e913f58f7e85f07fb9b995fabcf1df857d62"}, "author": "", "url": "https://uk.reuters.com/video/2018/05/25/bayer-cuts-monsanto-synergy-target-by-30?videoId=430252473", "ord_in_thread": 0, "title": "Bayer cuts Monsanto synergy target by $300 mln", "locations": [], "entities": {"persons": [{"name": "kate king", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "monsanto", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Bayer cuts Monsanto synergy target by $300 mln 5:49pm BST - 01:59\nPharmaceutical and life science multi-national Bayer said on Friday that positive synergy effects from the planned takeover of U.S. seeds maker Monsanto would be about $300 million below its previous target because it will sell more businesses than initially expected to get antitrust approval. Kate King reports. ▲ Hide Transcript ▶ View Transcript\nPharmaceutical and life science multi-national Bayer said on Friday that positive synergy effects from the planned takeover of U.S. seeds maker Monsanto would be about $300 million below its previous target because it will sell more businesses than initially expected to get antitrust approval. Kate King reports. Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code https://reut.rs/2GOb8cT", "external_links": ["https://s3.reutersmedia.net/resources/r/?d=20180525&i=OV8HDAOP7&w=576&r=OV8HDAOP7&t=2", "https://reut.rs/2GOb8cT"], "published": "2018-05-25T19:49:00.000+03:00", "crawled": "2018-05-25T23:29:32.006+03:00", "highlightTitle": ""}